Literature DB >> 10640692

AP-2beta represses D(1A) dopamine receptor gene transcription in neuro2a cells.

S Takeuchi1, I Imafuku, M Waragai, C Roth, I Kanazawa, R Buettner, M M Mouradian, H Okazawa.   

Abstract

Expression of the D(1A) dopamine receptor in brain is restricted to specific neuronal populations. To investigate the mechanism of this selective expression, we localized a silencer upstream of the human D(1A) gene and identified its binding transcription factor in the D(1A)-negative neural cell line Neuro2a. Using deletion CAT analysis, we narrowed this silencer to the region between nucleotides -561 and -532 relative to the CAP site. This 30-bp region, designated D1AS1, contains a sequence homologous to the AP-2 binding site and binds to a factor that also interacts with the AP-2 consensus sequence. In gel supershift assays, this factor is recognized by anti-AP-2beta antibody. Co-transfection of Neuro2a cells with an AP-2beta expression vector repressed the basal CAT activity of D(1A) promoter-reporter plasmids in a D1AS1-dependent manner. RT-PCR analysis indicated that, among AP-2 family members, Neuro2a cells express only AP-2beta. Furthermore, co-transfection of these cells with decoy oligonucleotides corresponding to the D1AS1 sequence de-repressed the D(1A) gene promoter. Unlike in Neuro2a cells, AP-2beta could not repress the D(1A) promoter in the D(1A)-positive neural cell line, NS20Y. In addition, the expression of AP-2beta in different brain regions does not inversely correlate with that of D(1A) dopamine receptor. These observations taken together indicate that AP-2beta is a repressive transcription factor that acts on the D1AS1 silencer of the D(1A) dopamine receptor gene via some cell-specific mechanism(s) in Neuro2a.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10640692     DOI: 10.1016/s0169-328x(99)00298-3

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  6 in total

Review 1.  Therapeutic applications of transcription factor decoy oligonucleotides.

Authors:  M J Mann; V J Dzau
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

Review 2.  Transcription factor AP-2 and monoaminergic functions in the central nervous system.

Authors:  M Damberg
Journal:  J Neural Transm (Vienna)       Date:  2005-06-15       Impact factor: 3.575

3.  Analysis of the Promoter Region of Human Dopamine Receptor D1.

Authors:  Xue Wu; Feng-Ling Xu; Bao-Jie Wang; Jun Yao
Journal:  J Mol Neurosci       Date:  2018-07-18       Impact factor: 3.444

4.  Microsatellite polymorphisms associated with human behavioural and psychological phenotypes including a gene-environment interaction.

Authors:  Andrew T M Bagshaw; L John Horwood; David M Fergusson; Neil J Gemmell; Martin A Kennedy
Journal:  BMC Med Genet       Date:  2017-02-03       Impact factor: 2.103

5.  Methamphetamine induces Shati/Nat8L expression in the mouse nucleus accumbens via CREB- and dopamine D1 receptor-dependent mechanism.

Authors:  Kyosuke Uno; Toh Miyazaki; Kengo Sodeyama; Yoshiaki Miyamoto; Atsumi Nitta
Journal:  PLoS One       Date:  2017-03-20       Impact factor: 3.240

Review 6.  The regulatory role of AP-2β in monoaminergic neurotransmitter systems: insights on its signalling pathway, linked disorders and theragnostic potential.

Authors:  Mohamed H Al-Sabri; Maryam Nikpour; Laura E Clemensson; Misty M Attwood; Michael J Williams; Mathias Rask-Anderson; Jessica Mwinyi; Helgi B Schiöth
Journal:  Cell Biosci       Date:  2022-09-08       Impact factor: 9.584

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.